Neil D Gross, M.D., F.A.C.S.

Head Shot of Neil Gross

Assistant Professor

click here


Dr. Gross is a dedicated surgeon-scientist with a passion for the highest quality clinical care and cancer research. His clinical interests include the diagnosis and treatment of aggressive skin cancers including melanoma, head and neck squamous cell cancers, thyroid and parathyroid disease, salivary gland and skull base tumors. His current research efforts are focused on the development and validation of improved prognostic tools for head and neck and thyroid cancer patients, the study of the molecular basis of carcinogenesis and the application of novel molecular therapeutics. He collaborates with Drs. Molly Kulesz-Martin and Melissa Wong in the Department of Dermatology for basic and translational scientific projects. Dr. Gross is the director of head and neck cancer clinical trials at the Knight Cancer Institute and is actively involved in numerous collaborative and multi-institutional studies.


Dr. Gross has been the recipient of numerous honors and awards including Alpha Omega Alpha, the National Institutes of Health Ruth L. Kirschstein National Research Service Award and Clinical Research Loan Repayment Program Award.  He has authored over 25 peer-reviewed research articles and is an invited guest lecturer nationally. He has also been the recipient of the prestigious American Society of Clinical Oncology Young Investigator Award, the American Association for Cancer Research-Gerald B. Grindey Memorial Scholar-in-Training Award and the American Head and Neck Society/American Academy of Otolaryngology-Head and Neck Surgery Surgeon Scientist Career Development Award.

Summary of Current Research

Additional Special Interests:

Aggressive skin cancer

Function-preserving multidisciplinary treatment for all head and neck cancers



2009 American Head and Neck Society/America Academy of Otolaryngology – Head and Neck Surgery Surgeon Scientist Combined Award

Selected Publications

"Hybrid capture 2 is as effective as pcr testing for high-risk human papillomavirus in head and neck cancers," Diagnostic Molecular Pathology - 2014

"Robotic Approaches to the Pharynx. Tonsil Cancer," Otolaryngologic Clinics of North America (Vol: 47, Issue: 3, Page 359-372) - 2014

"Robotic Surgery of the Head and Neck," Otolaryngologic Clinics of North America (Vol: 47, Issue: 3, Page ix-x) - 2014

"An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy," JAMA Otolaryngology - Head and Neck Surgery (Vol: 139, Issue: 6, Page 554-559) - 2013

"Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: Potential for dual inhibition as a therapeutic modality," Head and Neck (Vol: 35, Issue: 1, Page 86-93) - 2013


OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


  Email Neil Gross

503 494-5355

Memberships & Associations

American College of Surgeons
The Triological Society
Oregon Academy of Otolaryngology
American Academy of Otolaryngology – Head and Neck Surgery
American Society of Clinical Oncology
American Head and Neck Society